citrulline has been researched along with Diabetic Nephropathies in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Cao, P; Cao, R; Cao, Y; Chi, C; Hong, M; Huang, B; Jiang, Y; Li, S | 1 |
Fasching, A; Hansell, P; Palm, F; Persson, P; Teerlink, T | 1 |
Awad, AS; Cooper, TK; Gao, T; Morris, SM; You, H | 1 |
Edlund, J; Fasching, A; Hansell, P; Liss, P; Palm, F | 1 |
Anderson, S; Komers, R; Lindsley, JN; Oyama, TT | 1 |
Bellinghieri, G; De Luca, G; Di Giorgio, RM; Mallamace, A; Santoro, D; Savica, V | 1 |
Carlsson, PO; Friederich, M; Hansell, P; Liss, P; Palm, F; Teerlink, T | 1 |
Allison, KM; Anderson, S; Komers, R; Lindsley, JN; Oyama, TT | 1 |
1 review(s) available for citrulline and Diabetic Nephropathies
Article | Year |
---|---|
L-arginine: a new opportunity in the management of clinical derangements in dialysis patients.
Topics: Adult; Aged; Animals; Arginine; Citrulline; Diabetic Nephropathies; Endothelium, Vascular; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide; Renal Dialysis | 2006 |
7 other study(ies) available for citrulline and Diabetic Nephropathies
Article | Year |
---|---|
Association of amino acids related to urea cycle with risk of diabetic nephropathy in two independent cross-sectional studies of Chinese adults.
Topics: Adult; Arginine; Citrulline; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Humans; Ornithine; Urea | 2022 |
L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.
Topics: Animals; Arginine; Citrulline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Oxygen Consumption; Proteinuria; Rats | 2014 |
Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.
Topics: Amino Acids; Animals; Arginase; Arginine; Blood Pressure; Citrulline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Fibronectins; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred DBA; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Tumor Necrosis Factor-alpha | 2014 |
The roles of NADPH-oxidase and nNOS for the increased oxidative stress and the oxygen consumption in the diabetic kidney.
Topics: Acetophenones; Animals; Citrulline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Male; NADPH Oxidases; Nitric Oxide Synthase Type I; Oxidative Stress; Oxygen Consumption; Rats; Rats, Inbred WF; Thiourea | 2010 |
Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats.
Topics: Animals; Citrulline; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Cortex; Male; Nephrectomy; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Prostaglandin-Endoperoxide Synthases; Protective Agents; Proteinuria; Rats; Rats, Sprague-Dawley; Thiourea | 2004 |
Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability.
Topics: alpha-Tocopherol; Animals; Antioxidants; Arginase; Arginine; Blood Pressure; Cationic Amino Acid Transporter 2; Cell Hypoxia; Citrulline; Diabetic Nephropathies; Glomerular Filtration Rate; Kidney Medulla; Liver; Male; Nitric Oxide; Ornithine; Oxidative Stress; Oxygen; Rats; Rats, Inbred WF; Regional Blood Flow | 2008 |
Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.
Topics: Animals; Citrulline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Glomerular Filtration Rate; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Thiourea; Vascular Resistance | 2000 |